ArticleHuman vaccines & immunotherapeutics2015

Cross-protection against influenza virus infection by intranasal administration of nucleoprotein-based vaccine with compound 48/80 adjuvant.

Mei Zheng et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.